跳至主要内容
临床试验/NCT03062332
NCT03062332Unknown不适用

Altered Fecal Microbiota Composition in Patients With Major Depressive Disorder and Bipolar Disorder

First Affiliated Hospital Xi'an Jiaotong University1 个研究点 分布在 1 个国家目标入组 240 人开始时间: 2020年1月16日最近更新:
适应症

试验速览

阶段
不适用
入组人数
240
试验地点
1
主要终点
Composition of the gut microbiota

研究概览

简要总结

Background: The gut microbiome is emerging as an important factor in regulating mental health yet it remains unclear what the target should be for psychiatric treatment. Investigators aim at elucidating the complement of the gut microbiome community for individuals with Major Depressive disorder (MDD) and Bipolar disorder (BD) relative to controls, and test for relationships with symptoms.

Methods: Investigators prospect to recruit subjects including patients and controls amount to 240. All subjects will be collected for blood and stool samples,assessed by clinical scales. Finally, analyzing the correlation among the metabolon in blood, microbiota in stool and clinical scales to obtain the possible interaction between diseases and gut microbiota.

详细描述

Background: MDD (Major Depressive disorder) and BD (Bipolar disorder), whose specific pathogenesis is still unclear, are both a multi-factorial disease being caused by biological, psychological and social factors. Accumulating evidence suggests that gut microbiota play an important role in brain functions and in the pathogenesis of neuropsychiatric diseases, such as autism, anxiety, as well as depression. No study has thus far compared the human gut microbiota among BD, MDD and the healthy control (HC). The aim of this study is to compare the composition of fecal microbiota among BD, MDD and HC. Furthermore, investigators aim at identifying direct correlations between human fecal microbiota (as a proxy for gut microbiota) and symptoms.

Methods:

  1. Investigators aim at recruiting human subjects in total 240, which including mania episode of bipolar disorder (40), depressive episode of bipolar disorder (40), mixed episode of bipolar disorder (40), first episode of major depressive disorder (40), recurrent episode of major depressive disorder (40), and healthy control (40). All patients, diagnosed according to the research criteria of the 10th revision of the International Statistical Classification of Diseases and Related Health Problems (ICD-10), come from The First Affiliated Hospital of Xi'an Jiaotong University and controls are healthy volunteers.
  2. Collecting blood and stool samples, evaluating clinical scales including Montgomery-Asberg Depression Scale (MADRS), Young Mania Rating Scale (YMRS), Hamilton Depression Scale (HAMD), Hamilton Anxiety Scale (HAMA), Measurement And Treatment Research To Improve Cognition In Schizophrenia (MATRICS) Consensus Cognitive Battery (MCCB), Clinical Global Impression (CGI) are all finished in first day after threshold.
  3. Measure the metabolon in blood such as S-CFA, and gut microbiota.
  4. Using Statistical Program for Social Sciences (SPSS) to compare general and clinical data among groups and analyze the correlation between the microbiota and symptoms.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
— 至 65 Years(Child, Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Conforms to the diagnosis of bipolar disorder or major depressive disorder.
  • Take antibiotics continuously less than 3 days in recent 3 months.
  • 17.5≦BMI≦30

排除标准

  • who is diagnosed with physical diseases and other mental diseases.
  • pregnant or lactational women
  • who is diagnosed with mental retardation.

结局指标

主要结局

Composition of the gut microbiota

时间窗: 3 months

The relative richness of the species, %

次要结局

  • metabolon(3 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验

The Gut Microbiota of Bipolar and Depression | 临床试验